インスリンパッチポンプ市場：モード、製品、適応疾患別-2025-2030年の世界予測

インスリンパッチポンプ市場は、2023年に11億5,000万米ドルと評価され、2024年には12億7,000万米ドルに達すると予測され、CAGR 10.65％で成長し、2030年には23億5,000万米ドルに達すると予測されています。

インスリンパッチポンプ市場は、糖尿病管理における重要なセグメントとして浮上しており、患者に正確で便利なインスリン投与を提供しています。インスリンパッチポンプは、皮膚に貼り付けるコンパクトなデバイスであり、毎日複数回の注射や大型のインスリンポンプといった従来のインスリン送達メカニズムに代わる、より負担の少ない代替手段を提供します。これらのパッチポンプは、使いやすさ、目立たないデザイン、リアルタイムのグルコースモニタリング機能などの特徴により生活の質を向上させるため、1型およびインスリン依存性の2型糖尿病患者にとって特に有益です。これらの治療機器に対するニーズは、世界の糖尿病有病率の増加、自己管理型糖尿病治療に対する需要の増加、高度な治療オプションに対する患者の意識の高まりによって高まっています。主な用途は持続的なインスリン投与とグルコースモニタリングで、小児と成人の糖尿病患者の両方に有益です。最終用途は病院、診療所、家庭と多岐にわたるが、これはこれらの機器の多用途性と幅広い普及の可能性を反映しています。

主な成長要因には、技術の進歩、糖尿病管理における人工知能の統合、支持的な規制状況などがあります。新興市場での製品供給の拡大や、リアルタイムのモニタリングとフィードバックのための接続機能の強化にチャンスが存在します。企業は、戦略的パートナーシップ、研究開発への投資、流通網の強化を通じて、こうした動向を活用することができます。しかし、市場成長は、デバイスの高コスト、償還の問題、効果的な使用のための厳格なトレーニングの必要性などの課題に直面しています。さらに、従来のインスリン投与方法との競合や、新技術の採用に対する患者の不安もあります。クローズドループ・システム、インスリン投与予測アルゴリズム、改良型バイオウェアラブル・センサーのような技術革新は、探求の機が熟している分野を提示しています。市場は急速な技術革新と競合環境を特徴としており、事業の持続的成功のためには俊敏性と強固なイノベーション・パイプラインが必要となります。企業は、こうした市場力学を効果的に乗り切るために、使いやすいデザイン、手頃な価格、患者エンゲージメント戦略の強化を優先すべきです。

市場力学：急速に進化するインスリンパッチポンプ市場における主要市場インサイトの解明

インスリンパッチポンプ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 糖尿病の罹患率と有病率の上昇
  • インスリン注射の簡便化の必要性
  • 各国政府からの援助の増加
• 市場抑制要因
  • 不利な保険政策によるインスリン費用の上昇
• 市場機会
  • 糖尿病管理機器の進歩
  • 技術的に高度なパッチポンプを開発するための投資の増加
  • 人工知能の活用とカスタムメイドのパッチポンプの利用可能性
• 市場の課題
  • 装置の複雑さによる使い勝手の悪さ

ポーターの5つの力：インスリンパッチポンプ市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：インスリンパッチポンプ市場における外部からの影響の把握

外部マクロ環境要因は、インスリンパッチポンプ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析インスリンパッチポンプ市場における競合情勢の把握

インスリンパッチポンプ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスインスリンパッチポンプ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、インスリンパッチポンプ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨インスリンパッチポンプ市場における成功への道筋を描く

インスリンパッチポンプ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 糖尿病の発症率と有病率の上昇
    • インスリン投与の容易さの必要性
    • 各国政府からの支援の拡大
  • 抑制要因
    • 不利な保険政策によるインスリン費用の上昇
  • 機会
    • 糖尿病管理機器の進歩
    • 技術的に高度なパッチポンプの開発への投資増加
    • 人工知能の活用とカスタムメイドのパッチポンプの提供
  • 課題
    • デバイスの複雑さによりユーザーフレンドリーさが劣る
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 インスリンパッチポンプ市場モード別

• 基礎
• ボーラス

第7章 インスリンパッチポンプ市場：製品別

• 使い捨て
• 再利用可能

第8章 インスリンパッチポンプ市場：疾患適応症別

• 1型糖尿病
• 2型糖尿病

第9章 南北アメリカのインスリンパッチポンプ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のインスリンパッチポンプ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのインスリンパッチポンプ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• A. Menarini Industrie Farmaceutiche Riunite S.r.l.
• Abbott Laboratories
• Becton, Dickinson and Company
• CeQur SA
• Debiotech S.A.
• EOFlow Co., Ltd.
• F. Hoffmann-La Roche Ltd.
• Insulet Corporation
• Kaleido by ViCentra B.V.
• London Diabetes Centre
• Sanofi S.A.
• Sigi by AMF Medical
• Tandem Diabetes Care, Inc.
• Terumo Group
• Ypsomed AG

LIST OF FIGURES

• FIGURE 1. INSULIN PATCH PUMPS MARKET RESEARCH PROCESS
• FIGURE 2. INSULIN PATCH PUMPS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS INSULIN PATCH PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS INSULIN PATCH PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES INSULIN PATCH PUMPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES INSULIN PATCH PUMPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC INSULIN PATCH PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC INSULIN PATCH PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INSULIN PATCH PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INSULIN PATCH PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. INSULIN PATCH PUMPS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. INSULIN PATCH PUMPS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INSULIN PATCH PUMPS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INSULIN PATCH PUMPS MARKET DYNAMICS
• TABLE 7. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY BASAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY BOLUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INSULIN PATCH PUMPS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS INSULIN PATCH PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. CANADA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 27. CANADA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. CANADA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES INSULIN PATCH PUMPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC INSULIN PATCH PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. CHINA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 44. CHINA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. CHINA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. INDIA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 47. INDIA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. INDIA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA INSULIN PATCH PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. ITALY INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 99. ITALY INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. ITALY INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. POLAND INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 111. POLAND INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. POLAND INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. QATAR INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 114. QATAR INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. QATAR INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM INSULIN PATCH PUMPS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM INSULIN PATCH PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM INSULIN PATCH PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. INSULIN PATCH PUMPS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 144. INSULIN PATCH PUMPS MARKET, FPNV POSITIONING MATRIX, 2023

The Insulin Patch Pumps Market was valued at USD 1.15 billion in 2023, expected to reach USD 1.27 billion in 2024, and is projected to grow at a CAGR of 10.65%, to USD 2.35 billion by 2030.

The insulin patch pump market is emerging as a significant segment in diabetes management, providing patients with precise and convenient insulin delivery. Insulin patch pumps are compact devices that adhere to the skin, offering a less intrusive alternative to traditional insulin delivery mechanisms such as multiple daily injections or larger insulin pumps. These patch pumps are especially beneficial for type 1 and insulin-dependent type 2 diabetes patients as they enhance quality of life with features like ease of use, discrete design, and real-time glucose monitoring capabilities. The need for these devices is driven by the growing prevalence of diabetes globally, increasing demand for self-managed diabetes care, and heightened patient awareness about advanced treatment options. Applications predominantly focus on continuous insulin delivery and glucose monitoring, beneficial for both pediatric and adult diabetic populations. The end-use scope spans hospitals, clinics, and home settings, reflecting the versatility and broad adoption potential of these devices.

Key growth factors include technological advancements, integration of artificial intelligence in diabetes management, and a supportive regulatory landscape. Opportunities exist in expanding product availability in emerging markets and enhancing connectivity features for real-time monitoring and feedback. Companies can capitalize on these trends through strategic partnerships, investment in R&D, and strengthening distribution networks. However, market growth faces challenges including high costs of devices, reimbursement issues, and the need for rigorous training for effective use. Moreover, there is competition from traditional insulin delivery methods and apprehension among patients about adopting new technologies. Innovations such as closed-loop systems, predictive algorithms for insulin dosing, and improved biowearable sensors present areas ripe for exploration. The market is characterized by rapid technological changes and a competitive environment, necessitating agility and robust innovation pipelines for sustained business success. Companies should prioritize user-friendly designs, affordability, and enhanced patient engagement strategies to navigate these market dynamics effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Insulin Patch Pumps Market

The Insulin Patch Pumps Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence and prevalence of diabetes
  • Need for ease in the delivery of insulin
  • Increasing assistance from various governments
• Market Restraints
  • Rise in insulin cost with unfavorable insurance policies
• Market Opportunities
  • Advancement in diabetes management devices
  • Growing investment to develop technically advanced patch pumps
  • Use of artificial intelligence and availability of custom-made patch pumps
• Market Challenges
  • Less user friendliness due to complexity of the device

Porter's Five Forces: A Strategic Tool for Navigating the Insulin Patch Pumps Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Insulin Patch Pumps Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Insulin Patch Pumps Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Insulin Patch Pumps Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Insulin Patch Pumps Market

A detailed market share analysis in the Insulin Patch Pumps Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Insulin Patch Pumps Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Insulin Patch Pumps Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Insulin Patch Pumps Market

A strategic analysis of the Insulin Patch Pumps Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Insulin Patch Pumps Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Industrie Farmaceutiche Riunite S.r.l., Abbott Laboratories, Becton, Dickinson and Company, CeQur SA, Debiotech S.A., EOFlow Co., Ltd., F. Hoffmann-La Roche Ltd., Insulet Corporation, Kaleido by ViCentra B.V., London Diabetes Centre, Sanofi S.A., Sigi by AMF Medical, Tandem Diabetes Care, Inc., Terumo Group, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Insulin Patch Pumps Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Mode, market is studied across Basal and Bolus.
• Based on Product, market is studied across Disposable and Reusable.
• Based on Disease Indication, market is studied across Type 1 Diabetes and Type 2 Diabetes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence and prevalence of diabetes
    • 5.1.1.2. Need for ease in the delivery of insulin
    • 5.1.1.3. Increasing assistance from various governments
  • 5.1.2. Restraints
    • 5.1.2.1. Rise in insulin cost with unfavorable insurance policies
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancement in diabetes management devices
    • 5.1.3.2. Growing investment to develop technically advanced patch pumps
    • 5.1.3.3. Use of artificial intelligence and availability of custom-made patch pumps
  • 5.1.4. Challenges
    • 5.1.4.1. Less user friendliness due to complexity of the device
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Insulin Patch Pumps Market, by Mode

• 6.1. Introduction
• 6.2. Basal
• 6.3. Bolus

7. Insulin Patch Pumps Market, by Product

• 7.1. Introduction
• 7.2. Disposable
• 7.3. Reusable

8. Insulin Patch Pumps Market, by Disease Indication

• 8.1. Introduction
• 8.2. Type 1 Diabetes
• 8.3. Type 2 Diabetes

9. Americas Insulin Patch Pumps Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Insulin Patch Pumps Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Insulin Patch Pumps Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. A. Menarini Industrie Farmaceutiche Riunite S.r.l.
• 2. Abbott Laboratories
• 3. Becton, Dickinson and Company
• 4. CeQur SA
• 5. Debiotech S.A.
• 6. EOFlow Co., Ltd.
• 7. F. Hoffmann-La Roche Ltd.
• 8. Insulet Corporation
• 9. Kaleido by ViCentra B.V.
• 10. London Diabetes Centre
• 11. Sanofi S.A.
• 12. Sigi by AMF Medical
• 13. Tandem Diabetes Care, Inc.
• 14. Terumo Group
• 15. Ypsomed AG